Objective: To investigate the effect of clinicopathological variables on postoperative survival for patients with confined tumors (grade pT1b-4a) without lymph node metastases in thoracic esophageal squamous cell carcinoma (ESCC). Methods: 112 thoracic ESCC patients who had undergone radical surgical resection and been confirmed as pT1b-4aN0M0 enrolled in this study. Cox regression analysis was employed to identify the factors affecting the postoperative survival. Correlations between tumor length and other factors were surveyed. Results: In the groups, the overall 2-, 3-and 5-year survival rates were 97.3%, 71.5%, and 62.3%, respectively. The 2-, 3-and 5-year disease-free survival rates were 84.8%, 64.7%, and 57.2%, respectively. In multivariate analysis based on cox regression, T4a (HR 1.373, 95%CI:1.047-1.801; P=0.022), lower tumor differentiation (HR 1.462, 95%CI:1.053-2.031; P=0.023), and age ≤ 50 years(HR 2.530, 95%CI:1.126~5.684; P=0.025)affected overall survival term significantly. Lower tumor differentiation (HR 1.614, 95%CI:1.188-2.193; P=0.002), age ≤ 50 years (HR 2.684, 95%CI:1.266~5.691;P=0.010), tumor length>4 cm (HR 2.097, 95%CI:1.136~3.870;P=0.018) affected Disease-free survival significantly. There was a significant association between tumor length and T status (r=0.298, P=0.002).Conclusions: 1) T4a, Lower tumor differentiation, and age ≤ 50 years were the independent prognostic factors for overall survival. 2) Lower tumor differentiation, age ≤ 50 years, and tumor length>4 cm were the independent prognostic factors for disease-free survival. The great correlations of tumor length with depth of tumor invasion (T status) may account for its independent clinical value. Thoracic ESCC patients with the above high risk factors affecting postoperative survival should be treated with adjuvant therapy. Maybe it could improve the prognosis for these patients. |
[1] GRIFFITHSE EA,BRUMMELL Z,GORTHI G,et al.Tumor length as a prognostic factor in esophageal malignancy:univariate and multivariate survival analysis[J].J Surg Oncol,2006,93(4):258-267.
[2] 杨宏,傅剑华.以手术为主的食管癌综合治疗的进展[J].世界华人消化杂志,2012,20(35):3471-3475.
[3] CHEN J,PAN J,ZHENG X,et al.Number and location of positive nodes,postoperative radiotherapy,and survival after esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma[J].Int J Radiat Oncol Biol Phys,2012,82(1):475-482.
[4] GODFREY T E,RAJA S,FINKELSTEIN S D.Prognostic value of quantitative reverse transcription-polymerase chain reaction in lymph node negative esophageal cancer patients[J].Clin Cancer Res,2001,7(12):4041-4048.
[5] 吴海山,陈俊强,朱坤寿,等.N0期食管鳞癌术后预后因素及术后放疗价值探讨[J].实用临床医药杂志,2009,13(10):22-25.
[6] 朱自江,陈学忠,牛荣,等.食管癌患者术后肿瘤复发和转移的危险因素分析[J].中国胸心血管外科临床杂志,2011,18(6):521-525.
[7] 张冬坤,苏晓东,林鹏,等.467例Ⅱ期胸段食管鳞癌切除术后患者的生存分析[J].癌症,2008,27(2):113-118.
[8] 刘彦中.青年人与老年人食管癌的临床研究[J].医师进修杂志:外科版,2004,27(8):48-49.
[9] 许贤荣,俞力超,李峰,等.食管癌颈胸腹三区域淋巴结清扫术与预后的关系研究[J].现代预防医学,2007,34(23):4586-4587.
[10] 崔纪丽,侯志超,刘玉,等.食管癌患者肿瘤最长径与浸润深度和淋巴结转移的关系及其对生存期的影响[J].肿瘤防治研究,2014,41(3):214-220.
[11] FENG J F,HUANG Y,ZHAO Q.Tumor length in elderly patients with esophageal squamous cell carcinoma:is it a prognostic factor?[J].Ups J Med Sci,2013,118(3):145-152.
[12] SONG Z,WANG J,LIN B,et al.Analysis of the tumor length and other prognosis factors in pT1-2 node-negative esophageal squamous cell carcinoma in a Chinese population[J].World J Surg Oncol.2012,10:273.
[13] 邵明雯,陈亮,李红霞,等.病变长度对淋巴结阴性食管癌患者的临床病理及预后影响[J].中国癌症杂志,2014,24(11):846-851.
[14] MA M Q,YU Z T,TANG P,et al.Is tumor length a prognostic indicator for esophageal squamous cell carcinoma? A single larger study among Chinese patients[J].Int J Clin Exp Pathol,2015,8(5):5008-5016.
[15] NAKAGAWA S,KANDA T,KOSUGI S,et al.Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy[J].J Am Coll Surg,2004,198(2):205-211. |